EUA
cPass SARS-CoV-2 Neutralization Antibody Detection Kit
FDA Emergency Use Authorization · GenScript USA Inc. · Feb 1, 2022
Key facts
| Product | cPass SARS-CoV-2 Neutralization Antibody Detection Kit |
|---|---|
| Company | GenScript USA Inc. |
| Product type | Total Neutralizing Antibodies, Blocking ELISA, Semi-quantitative |
| Date | Feb 1, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: